Mônica Bergamo: Cremesp will investigate the ranking of cannabis products associated with the founder of Dr. Query

Cremesp (Regional Council of Medicine of São Paulo) will open an investigation to investigate a website that publishes a ranking of medicinal cannabis-based products, whose use is controlled by Anvisa (National Health Surveillance Agency). The domain is registered in the name of urologist Cesar Camara, one of the founders of Dr. Query.

LIVE EYE

Camara is also CEO of the company Biocase, which manufactures products with CBD (cannabidiol, a therapeutic substance derived from the plant, with no psychoactive effect). One of the oils made by the factory appears first on one of the lists on the platform that will be investigated, titled “Green List”.

TICKET WINDOW

In the “about us” tab, the site says that it “seeks to classify the numerous products available in the Brazilian market” — but does not mention Camara. The website also states that the rating given to the products “is defined from the availability of information on the manufacturers’ website”.

SILENCE

The director of BRCANN, association of the cannabinoid industries, Tarso Araújo, says that associates have already complained about the site for displaying products without the authorization of the manufacturers. He claims the ranking “clearly is false advertising”. “The undue promotion of cannabidiol products is today the most common type of regulatory infringement on the market and we have been working to raise awareness of these rules to avoid this type of conduct”, he continues.

MAGNIFYING GLASS

The column sought out the CFM (Federal Council of Medicine), Cremesp and Anvisa between the 10th and 11th of May. The CFM said that it “refrain from commenting on specific cases” and Anvisa said that the case was sent for analysis.

NOT HERE

Camara says he registered the site in his name at the request of a woman he met at a course, and denies he owns it. He also states that the inquiry will be another opportunity to publicize and explain cannabinoid medicine in Brazil, but that the “Green List” “is an important site because it ranks very consistently and takes a lot of supposedly TOP product off the pedestal” .

NOT HERE 2

The website was created in her name in 2019, but the registration was changed to Edelma Martins on May 10 of this year – the date on which the column sought out the bodies for clarification.

OF ALL

Chairman of the board of directors of Incor (Instituto do Coração), cardiologist Roberto Kalil Filho says that the SUS (Unified Health System) was one of “the great heroes” of Brazil in the pandemic, alongside the vaccine against Covid. The doctor, however, regrets that the system does not receive the attention it deserves from all “governments in recent decades”.

Kalil says he is interested in having a more active political participation in the future. “By 80, I’m going to be a candidate for something,” she reveals. “Right now, my mandate is my patients,” she says.

The doctor is also general director of the Cardiology Center at Hospital Sírio-Libanês and hosts the CNN Vital Signs program, which is in its second season on CNN Brasil.

​_{with BIANKA VIEIRA, KARINA MATIAS and MANOELLA SMITH}